Nephrogen
www.nephrogenbiotech.comNephrogen is a biotech company developing curative gene therapy drugs for kidney disease. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Read more
Nephrogen is a biotech company developing curative gene therapy drugs for kidney disease. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Read more
Country
State
New York
City (Headquarters)
New York City
Industry
Employees
1-10
Founded
2015
Social
Employees statistics
View all employeesPotential Decision Makers
Advisory Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(15)
Reach decision makers at Nephrogen
Free credits every month!
Nephrogen FAQ
New York City, United States
Biotechnology Research
